Ayurcann Holdings Statistics

Total Valuation

Ayurcann Holdings has a market cap or net worth of CAD 6.81 million. The enterprise value is 3.61 million.

Market Cap	6.81M
Enterprise Value	3.61M

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Ayurcann Holdings has 194.70 million shares outstanding. The number of shares has increased by 19.59% in one year.

Shares Outstanding	194.70M
Shares Change (YoY)	+19.59%
Shares Change (QoQ)	+20.09%
Owned by Insiders (%)	47.96%
Owned by Institutions (%)	n/a
Float	65.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.25
PB Ratio	2.21
P/FCF Ratio	3.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.81
EV / Sales	0.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1.71

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 20.39.

Current Ratio	1.02
Quick Ratio	0.60
Debt / Equity	20.39
Debt / EBITDA	n/a
Debt / FCF	0.30
Interest Coverage	-11.12

Financial Efficiency

Return on equity (ROE) is -100.89% and return on invested capital (ROIC) is -51.45%.

Return on Equity (ROE)	-100.89%
Return on Assets (ROA)	-18.00%
Return on Capital (ROIC)	-51.45%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.61
Inventory Turnover	3.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.00% in the last 52 weeks. The beta is 1.77, so Ayurcann Holdings's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	+40.00%
50-Day Moving Average	0.06
200-Day Moving Average	0.04
Relative Strength Index (RSI)	39.87
Average Volume (20 Days)	21,184

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ayurcann Holdings had revenue of CAD 23.28 million and -4.46 million in losses. Loss per share was -0.03.

Revenue	23.28M
Gross Profit	7.96M
Operating Income	-4.15M
Pretax Income	-4.46M
Net Income	-4.46M
EBITDA	-3.14M
EBIT	-4.15M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 3.83 million in cash and 628,940 in debt, giving a net cash position of 3.20 million or 0.02 per share.

Cash & Cash Equivalents	3.83M
Total Debt	628,940
Net Cash	3.20M
Net Cash Per Share	0.02
Equity (Book Value)	3.08M
Book Value Per Share	0.02
Working Capital	280,025

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.63 million and capital expenditures -523,003, giving a free cash flow of 2.11 million.

Operating Cash Flow	2.63M
Capital Expenditures	-523,003
Free Cash Flow	2.11M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 34.21%, with operating and profit margins of -17.84% and -19.17%.

Gross Margin	34.21%
Operating Margin	-17.84%
Pretax Margin	-19.17%
Profit Margin	-19.17%
EBITDA Margin	-13.51%
EBIT Margin	-17.84%
FCF Margin	9.05%

Dividends & Yields

Ayurcann Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.59%
Shareholder Yield	-19.59%
Earnings Yield	-75.69%
FCF Yield	30.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ayurcann Holdings has an Altman Z-Score of -0.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.14
Piotroski F-Score	n/a